German startup Pieris hopes they could prove a cheaper alternative to antibodies. (Click here for company profile.) The structure of lipocalins was first elucidated during the early 1980s ...

Cinrebafusp alfa is under clinical development by Pieris Pharmaceuticals and currently in Phase I for Esophageal Cancer. According to GlobalData, Phase I drugs for Esophageal Cancer have an 80% phase ...

Pieris Pharmaceuticals’ long-standing immuno-oncology alliance with Servier is being dissolved after a clinical trial of the lead drug in the alliance revealed a safety concern. In a Securities ...

Stock analysts at StockNews.com assumed coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Get Free Report) in a research note issued to investors on Friday. The brokerage set a “hold” rating ...

WAYNE, PA — Palvella Therapeutics, Inc. has completed its merger with Pieris Pharmaceuticals, Inc., forming a unified company under the name Palvella Therapeutics, Inc. Shares of the newly ...

See Correction/Clarification at the end of this article. After losing a major partnership last year, the Boston biotech Pieris Pharmaceutical has been searching for a path forward. The biotech has ...

Mars is well-known for its dust storms, which occur every Martian year during summer in the southern hemisphere.

Understanding why storms sometimes engulf the entire planet within a layer of grit could prove crucial to future missions.

Analyst Andrew Fein of H.C. Wainwright reiterated a Buy rating on Palvella Therapeutics (PVLA – Research Report), retaining the price target of ...

The team discovered that relatively warm and sunny days may help to trigger them. Heshani Pieris, lead author of the study, said the findings are a first step toward forecasting extreme weather on ...